Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
Gold
Crude Oil
Local Stocks
Stocks of Local Interest
PG Energy Index
Local Stocks
Energy Stocks
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries
ARMO BioSciences, Inc. - Common Stock
(NQ:
ARMO
)
N/A
UNCHANGED
Last Price
Updated:
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All news about ARMO BioSciences, Inc. - Common Stock
< Previous
1
2
Next >
Asceneuron Appoints Peter Van Vlasselaer as Chairman
January 16, 2019
From
PR Newswire
The Week Ahead: FANG Earnings Continue, Fox Vote On Disney Deal, More IPOs
July 23, 2018
Below is a list of notable corporate events for the week beginning July 23. Note, this list is not comprehensive and all dates are ...
Tags
LOVE
WHR
HYRE
From
Benzinga
Lilly Completes Acquisition of ARMO BioSciences
June 22, 2018
Eli Lilly and Company (NYSE: LLY) today announced the successful completion of its acquisition of ARMO BioSciences, Inc. (NASDAQ: ARMO).
From
PR Newswire
Loncar Cancer Immunotherapy Index Conducts Semi-Annual Rebalance
June 20, 2018
Loncar Cancer Immunotherapy Index Conducts Semi-Annual Rebalance. Six New Biotechnology Companies Added to the Index.
From
Business Wire News Releases
Better Buy: Johnson & Johnson vs. Eli Lilly
June 17, 2018
Which of these big pharma stocks has a better chance to outperform for your portfolio.
Tags
Market News
LLY
ARMO
From
Motley Fool
Lifshitz & Miller LLP Announces Investigation of ARMO BioSciences, Inc., Financial Engines, Inc., Globalstar, Inc., Gridsum Holding Inc., InnerWorkings, Inc., Incyte Corporation, PPG Industries, Inc.,
June 05, 2018
From
PR Newswire
The Week Ahead In Biotech: ASCO Presentations Dominate The Headlines
June 03, 2018
A few FDA approvals and the impending 2018 American Society of Clinical Oncology annual meeting gave some impetus to the biotech space ...
Tags
SPPI
NVS
General
From
Benzinga
SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of ARMO BioSciences, Inc. Buyout
May 24, 2018
SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of ARMO BioSciences, Inc. Buyout
From
Business Wire News Releases
SHAREHOLDER ALERT: Monteverde & Associates PC Announces An Investigation Of ARMO BioSciences, Inc. - ARMO
May 18, 2018
Juan Monteverde, founder and managing partner at Monteverde & Associates PC, a national securities firm headquartered at the Empire State Building in New York City, is investigating ARMO BioSciences,...
From
PR Newswire
SHAREHOLDER ALERT: Brodsky & Smith, LLC Announces an Investigation of ARMO Biosciences, Inc. - ARMO
May 16, 2018
From
ACCESSWIRE
Biotech Sector Volatile Ahead of Trump Announcement
May 15, 2018
From
PR Newswire
NASDAQ:ARMO Investor Alert: Investigation over Possible Wrongdoing in Acquisition of ARMO BioSciences, Inc
May 14, 2018
San Diego, CA -- (SBWIRE) -- 05/14/2018 -- An investigation was announced for investors, who currently hold shares of ARMO BioSciences, Inc. (NASDAQ: ARMO),over the takeover of ARMO BioSciences, Inc....
From
SBWire - Latest Press Releases
WeissLaw LLP: ARMO BioSciences Inc. Acquisition May Not Be In The Best Interests of ARMO shareholders
May 14, 2018
WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the Board of Directors of ARMO BioSciences Inc. ("ARMO" or the "Company") (NASDAQ: ARMO) in connection...
From
PR Newswire
UPDATE 1-Lilly to buy cancer drug developer AurKa Pharma
May 14, 2018
May 14 (Reuters) - Eli Lilly and Co will buy AurKa Pharma Inc in a deal potentially worth up to $575 million, the U.S. drugmaker said on Monday, seeking access to the privately-held firm's experimental...
Tags
companyNews
From
Reuters: Company News
Week In Review: $3.4 Billion Week For China Life Science Deals
May 12, 2018
Armo Biosciences, a Bay Area immuno-oncology company, agreed to be acquired by Eli Lilly. Lilly offered to pay $50 per share for Armo, a three-fold increase from the IPO price and a 67% jump from its...
Tags
Pharma/Biotech
Stocks / Equities
From
Blogs - TalkMarkets
3 Biotech Stocks That Soared This Week: Are They Buys?
May 12, 2018
Can the momentum keep going for these sizzling-hot biotech stocks?
Tags
OPK
LLY
Market News
From
Motley Fool
Week in Review: $3.4 Billion Week for China Life Science Deals
May 11, 2018
Deals and Financings Armo Biosciences, a Bay Area immuno-oncology company backed by China investors, will be acquired by Eli Lilly in a $1.6 billion transaction; Luye Pharma of Yantai will pay $538...
From
ChinaBio® Today
Benzinga's Top Upgrades, Downgrades For May 11, 2018
May 11, 2018
Top Upgrades JP Morgan upgraded Verizon Communications Inc. (NYSE: VZ) from Neutral to Overweight. Verizon shares rose 0.97 ...
Tags
TGI
CISN
QTWO
From
Benzinga
55 Biggest Movers From Yesterday
May 10, 2018
Gainers ARMO BioSciences, Inc. (NASDAQ: ARMO) shares gained 67 percent to close at $49.80 after Eli Lilly and Company (NYSE: ...
Tags
KNDI
Movers From Yesterday
LLY
From
Benzinga
SHAREHOLDER NOTICE: Brodsky & Smith, LLC Announces an Investigation of ARMO Biosciences, Inc. - ARMO
May 10, 2018
From
ACCESSWIRE
Biotech Stocks Underperform Market: CELG, EXEL, PBYI, XBI
May 10, 2018
Biotechs underperformed despite a good opening with the XBI trying to break through the SMA 50 level but fell back around mid-day.
Tags
Stocks / Equities
Pharma/Biotech
Healthcare
From
Blogs - TalkMarkets
Markets soar on mild inflation
May 10, 2018
Mild inflation data sent the markets soaring to a sharply higher close with the Dow leaping 196 points to 24,739. Nasdaq climbed 65 points to 7404.
Tags
Market News
From
MarketMinute.com Market Updates
Eli Lilly to buy ARMO BioSciences
May 10, 2018
ARMO BioSciences Inc. (Nasdaq: ARMO) will be acquired by Eli Lilly (NYSE: LLY) for a premium of approximately $1.6 billion in cash. Shares of ARMO BioSciences rocketed $19.98 to close at $49.80 while...
From
MarketMinute.com Stock News
Bragar Eagel & Squire, P.C. is Investigating the Board of Directors of ARMO BioSciences, Inc. (ARMO) on Behalf of Stockholders and Encourages Investors to Contact the Firm
May 10, 2018
Bragar Eagel & Squire, is Investigating the Sale of ARMO BioSciences (ARMO) on Behalf of Stockholders and Encourages Investors to Contact the Firm
From
Business Wire News Releases
Why Spotify Technology, CenturyLink, and ARMO BioSciences Jumped Today
May 10, 2018
Find out why these stocks led the market higher.
Tags
CTL
SPOT
Market News
From
Motley Fool
Mid-Afternoon Market Update: Prestige Brands Gains On Earnings Beat; MDC Partners Shares Slide
May 10, 2018
Toward the end of trading Thursday, the Dow traded up 0.74 percent to 24,723.63 while the NASDAQ climbed 0.75 percent to 7,394.55. The ...
Tags
Markets
Intraday Update
PBH
From
Benzinga
ARMO Biosciences Soars 67% on $1.6 Billion Buyout
May 10, 2018
One of the largest pharma companies in the world moved to boost its cancer immunotherapy pipeline.
Tags
Market News
ARMO
LLY
From
Motley Fool
40 Stocks Moving In Thursday's Mid-Day Session
May 10, 2018
Gainers Turtle Beach Corporation (NASDAQ: HEAR) surged 87.1 percent to $12.98 after the company reported Q1 results and ...
Tags
MRAM
Intraday Update
LXFR
From
Benzinga
ARMO BIOSCIENCES, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation of Buyout
May 10, 2018
ARMO BIOSCIENCES, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation of Buyout
From
Business Wire News Releases
Mid-Day Market Update: Dow Rises 150 Points; Hudson Technologies Shares Plunge
May 10, 2018
Midway through trading Thursday, the Dow traded up 0.65 percent to 24,702.16 while the NASDAQ climbed 0.63 percent to 7,386.41. The ...
Tags
MDCA
HEAR
ARMO
From
Benzinga
< Previous
1
2
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.